H. R. Michels

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, M Bory, D Collen et al. · The Lancet · 1985 · 752 citations

Medicine, Cardiology, Pharmacology +10

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

Robbert J. de Winter, Fons Windhausen, Jan H. Cornel et al. · New England Journal of Medicine · 2005 · 538 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Familial Sudden Death Is an Important Risk Factor for Primary Ventricular Fibrillation

Lukas Dekker, Connie R. Bezzina, Josè P.S. Henriques et al. · Circulation · 2006 · 283 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.

Jacobus Lubsen, Jan G.P. Tijssen, Johan J. Kerkkamp et al. · Heart · 1986 · 270 citations · Full text

Medicine, Cardiology, Pharmacology +11

Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events

Nico H.J. Pijls, G. Jan Willem Bech, M.I.H. EL GAMAL et al. · Journal of the American College of Cardiology · 1995 · 235 citations

Medicine, Cardiology, Physiology +14